Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

597 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Investigation of inherited noncoding genetic variation impacting the pharmacogenomics of childhood acute lymphoblastic leukemia treatment.
Bhattarai KR, Mobley RJ, Barnett KR, Ferguson DC, Hansen BS, Diedrich JD, Bergeron BP, Yoshimura S, Yang W, Crews KR, Manring CS, Jabbour E, Paietta E, Litzow MR, Kornblau SM, Stock W, Inaba H, Jeha S, Pui CH, Cheng C, Pruett-Miller SM, Relling MV, Yang JJ, Evans WE, Savic D. Bhattarai KR, et al. Among authors: stock w. Nat Commun. 2024 May 1;15(1):3681. doi: 10.1038/s41467-024-48124-4. Nat Commun. 2024. PMID: 38693155 Free PMC article.
Epigenomic mapping in B-cell acute lymphoblastic leukemia identifies transcriptional regulators and noncoding variants promoting distinct chromatin architectures.
Barnett KR, Mobley RJ, Diedrich JD, Bergeron BP, Bhattarai KR, Yang W, Crews KR, Manring CS, Jabbour E, Paietta E, Litzow MR, Kornblau SM, Stock W, Inaba H, Jeha S, Pui CH, Mullighan CG, Relling MV, Yang JJ, Evans WE, Savic D. Barnett KR, et al. Among authors: stock w. bioRxiv [Preprint]. 2023 Jul 13:2023.02.14.528493. doi: 10.1101/2023.02.14.528493. bioRxiv. 2023. PMID: 36824825 Free PMC article. Updated. Preprint.
Epigenomic mapping reveals distinct B cell acute lymphoblastic leukemia chromatin architectures and regulators.
Barnett KR, Mobley RJ, Diedrich JD, Bergeron BP, Bhattarai KR, Monovich AC, Narina S, Yang W, Crews KR, Manring CS, Jabbour E, Paietta E, Litzow MR, Kornblau SM, Stock W, Inaba H, Jeha S, Pui CH, Mullighan CG, Relling MV, Pruett-Miller SM, Ryan RJH, Yang JJ, Evans WE, Savic D. Barnett KR, et al. Among authors: stock w. Cell Genom. 2023 Nov 20;3(12):100442. doi: 10.1016/j.xgen.2023.100442. eCollection 2023 Dec 13. Cell Genom. 2023. PMID: 38116118 Free PMC article.
Functional investigation of inherited noncoding genetic variation impacting the pharmacogenomics of childhood acute lymphoblastic leukemia treatment.
Bhattarai KR, Mobley RJ, Barnett KR, Ferguson DC, Hansen BS, Diedrich JD, Bergeron BP, Yang W, Crews KR, Manring CS, Jabbour E, Paietta E, Litzow MR, Kornblau SM, Stock W, Inaba H, Jeha S, Pui CH, Cheng C, Pruett-Miller SM, Relling MV, Yang JJ, Evans WE, Savic D. Bhattarai KR, et al. Among authors: stock w. medRxiv [Preprint]. 2023 Feb 11:2023.02.10.23285762. doi: 10.1101/2023.02.10.23285762. medRxiv. 2023. PMID: 36798219 Free PMC article. Updated. Preprint.
Air Pollutant Impact on Disease Characteristics and Outcomes in Patients with Acute Myeloid Leukemia.
Palmer AS, Rauscher GH, Abraham IE, Burkart M, Dave A, Raptis NI, Aleem A, Gannamani V, Erra A, Monick S, Galvez C, Shah SAM, Rahmani Youshanlouei H, Larson ML, Zia M, Tsai SB, Altman JK, Stock W, Khan I, Patel AA. Palmer AS, et al. Among authors: stock w. Blood Adv. 2024 May 29:bloodadvances.2024013280. doi: 10.1182/bloodadvances.2024013280. Online ahead of print. Blood Adv. 2024. PMID: 38810264 No abstract available.
Identifying long-term survivors and those at higher or lower risk of relapse among patients with cytogenetically normal acute myeloid leukemia using a high-dimensional mixture cure model.
Archer KJ, Fu H, Mrózek K, Nicolet D, Mims AS, Uy GL, Stock W, Byrd JC, Hiddemann W, Braess J, Spiekermann K, Metzeler KH, Herold T, Eisfeld AK. Archer KJ, et al. Among authors: stock w. J Hematol Oncol. 2024 May 3;17(1):28. doi: 10.1186/s13045-024-01553-6. J Hematol Oncol. 2024. PMID: 38702786 Free PMC article.
Expedited evaluation of hereditary hematopoietic malignancies in the setting of stem cell transplantation.
Roloff GW, Kosuri S, Nawas MT, DuVall AS, Patel AA, Riedell PA, Odenike O, Stock W, Larson RA, Bishop MR, Nunley E, Godley LA, Hathaway F, Del Gaudio D, Das S, Canham LE, Drazer MW. Roloff GW, et al. Among authors: stock w. Haematologica. 2024 Apr 11. doi: 10.3324/haematol.2023.284584. Online ahead of print. Haematologica. 2024. PMID: 38618681 Free article.
Association of leukemic molecular profile with efficacy of inotuzumab ozogamicin in adults with relapsed/refractory ALL.
Zhao Y, Laird AD, Roberts KG, Yafawi RL, Kantarjian HM, DeAngelo DJ, Stelljes M, Liedtke M, Stock W, Gökbuget N, O'Brien SM, Jabbour EJ, Cassaday RD, Loyd MR, Olsen SR, Neale GA, Liu X, Vandendries E, Advani AS, Mullighan CG. Zhao Y, et al. Among authors: stock w. Blood Adv. 2024 Mar 26:bloodadvances.2023012430. doi: 10.1182/bloodadvances.2023012430. Online ahead of print. Blood Adv. 2024. PMID: 38607410
597 results